Add BrightSurf on Google Email

Kidney disease measures are associated with structural brain damage across different domains of etiology

Reduced kidney function and increased urine albumin excretion are associated with brain volume reduction in regions typically affected by Alzheimer's disease and other dementia etiologies. Cognitive decline is common in patients with kidney disease, and this study provides new insights into the etiology and localization of brain damage.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateSep 27, 2022

New research provides employment figures of kidney transplant recipients

A recent study in the Netherlands provides an estimate of the proportion of working-aged kidney transplant recipients who are employed and identifies characteristics associated with lower work functioning. Despite side effects of immunosuppressive therapy and fatigue, stable kidney transplant recipients often function well at work.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateSep 26, 2022

As health problems stack up, so do serious financial woes, study shows

A new study from Michigan Medicine found that adults with more chronic health conditions are at higher risk of serious financial problems, including late payments, poor credit scores, and bankruptcy. The study analyzed nearly 3 million privately insured adults and found that those with seven or more chronic conditions had three to four...

SourceMichigan Medicine - University of Michigan·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateSep 20, 2022

How might eliminating race-based adjustments in estimates of kidney function affect kidney transplant waitlisting?

A new study finds that using race-free equations for estimating kidney function can minimize racial differences in accrued preemptive waiting time. The research suggests that a specific equation, creatinine-based, reduces racial disparities more effectively than another equation, cystatin C-based.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateSep 19, 2022

New technology offers pathways to finding treatments for kidney disease

Researchers at Washington University have developed a hydrogel system that preserves biochemistry and mechanical environments of cultured podocyte cells. This allows researchers to identify new ways to control mechanisms used by cells to heal themselves, potentially leading to therapies for currently incurable diseases.

SourceWashington University in St. Louis·JournalScience Advances·TypeExperimental study·DateAug 31, 2022

New labeling approach enables examination of packages cells send out to gain insight about health

Researchers have developed a new labeling technique to analyze exosomes from specific cell types, providing insights into their role in both health and disease. The technique allows for the identification of protein cargo and RNA in exosomes, enabling the study of cellular communication and potential monitoring of response to treatment.

SourceMedical College of Georgia at Augusta University·JournalJournal of Extracellular Vesicles·DateAug 30, 2022

Metabolism may be key to future treatment of kidney diseases

A new study from Aarhus University found that lysine, an amino acid supplement, protects laboratory animals from kidney damage and prevents hypertensive kidney disease. The research suggests that a diet rich in lysine may help prevent or treat kidney diseases, but more studies are needed to confirm the results.

SourceAarhus University·JournalNature Communications·TypeExperimental study·DateAug 19, 2022

Transplant candidates’ thoughts about tradeoffs of shorter wait time for lower quality kidneys

A recent study suggests that many patients on the transplant waitlist would accept lower quality kidneys in exchange for a shorter waiting time. The research identifies three patient-preference classes, with some respondents willing to accept increases in waiting time for small improvements in kidney quality.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateAug 19, 2022

Quality Improvement Program increases pneumococcal vaccination in adults with advanced kidney disease

A quality improvement program increased pneumococcal vaccination rates from 53% to 70% in adults aged 18-64 years with stage 4 and 5 chronic kidney disease. The intervention, which utilized electronic best practice alerts within the electronic medical record, improved vaccination rates primarily among this high-risk group.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateAug 17, 2022

Oncotarget | Kinase activity in renal cell carcinoma, benign renal tissue and in response to tyrosine kinase inhibitors

Researchers identified differences in PTK activity between normal and cancer kidney tissue, with Src family kinases and PI3K pathways exhibiting high activity. Ex vivo treatment of clear cell RCC with TKIs revealed that tivozanib and cabozantinib were more potent inhibitors than sunitinib or pazopanib.

SourceImpact Journals LLC·JournalOncotarget·TypeData/statistical analysis·DateAug 17, 2022

Pediatric kidney transplant patients fare better when kidney is from live donor

A new study published in Pediatric Transplantation found that pediatric kidney transplant patients have better long-term outcomes when their kidney comes from a living donor. The study analyzed data from the Organ Procurement and Transplant Network database and compared the rates of graft failure and death among children who received k...

SourceUniversity of California - Davis Health·JournalPediatric Transplantation·TypeData/statistical analysis·DateAug 15, 2022

Aldosterone linked to increased risk of chronic kidney disease progression and end-stage kidney disease

Higher aldosterone concentrations are associated with lower eGFR, lower potassium levels in blood, and higher potassium and protein concentrations in urine. The risk of CKD worsening was independent of diabetes status. Finerenone may help prevent CKD progression by targeting aldosterone's action.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateAug 8, 2022

Analysis reveals sex differences in the recognition, monitoring, and treatment of chronic kidney disease

Women are less likely to receive diagnostic codes related to CKD, be referred to a nephrologist, and have their kidney function monitored compared to men. Despite guidelines recommending equal care, women receive suboptimal management of chronic kidney disease, with lower rates of testing and guideline-recommended medications.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateJul 29, 2022

Immunosuppressive drug’s blood level variability may identify pediatric kidney transplant recipients at risk of rejection

Pediatric kidney transplant recipients with high tacrolimus intrapatient variability are at increased risk of developing antibodies against the transplanted kidney. This variability can be identified through hospital electronic health records, allowing for early intervention to prevent rejection and improve graft outcomes.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateJul 26, 2022

Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants

Researchers at the University of South Australia have discovered that combining anti-rejection medication with immune checkpoint inhibitors can significantly reduce the risk of organ rejection and eliminate cancer cells in a quarter of patients. The study involved 22 patients with renal transplants and incurable locally advanced or met...

SourceUniversity of South Australia·JournalThe Lancet Oncology·TypeExperimental study·DateJul 18, 2022

Lumasiran shows efficacy in adults with reduced GFR and primary hyperoxaluria type 1 (PH1)

Lumasiran, an RNA interference therapeutic, has been shown to reduce oxalate levels in patients with primary hyperoxaluria type 1 (PH1) who have relatively preserved kidney function. In the ILLUMINATE-C study, lumasiran resulted in substantial reductions in plasma oxalate with acceptable safety in patients on hemodialysis.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateJul 14, 2022

Widely-used kidney function tests underestimate scale of kidney disease in Africa

A study found that widely-used kidney function tests are inaccurate for predicting kidney disease in African populations, suggesting a significant underestimation of kidney disease prevalence. The creatinine-based test was shown to be less effective due to unique biological characteristics in African populations, while the cystatin C t...

SourceUniversity of the Witwatersrand·JournalThe Lancet Global Health·TypeExperimental study·DateJul 13, 2022

People from low socioeconomic backgrounds could reduce chronic kidney disease risk with regular exercise, study suggests

A study published in The American Journal of Medicine found that regular physical activity can substantially reduce the risk of chronic kidney disease in individuals from lower socioeconomic backgrounds. Participants with higher levels of fitness showed a significantly lower risk of developing the disease, even among those with low soc...

SourceUniversity of Bristol·JournalThe American Journal of Medicine·TypeObservational study·DateJul 12, 2022

Study finds better and safer treatment option than saline solution as IV fluid for emergency department and hospital patients

A new study published in JAMA Network Open found that patients who received lactated Ringer solution instead of normal saline for IV fluids had a lower risk of kidney injury and death. The study, which included nearly 150,000 hospital patients, showed a 2.2% reduced risk of major adverse kidney events.

SourceIntermountain Healthcare·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateJun 29, 2022

New approach to treatment of deadly kidney cancer

A new study from Karolinska Institutet has identified a key mechanism behind treatment resistance in a deadly form of kidney cancer. By increasing mitochondrial content in cancer cells, researchers found that these cells became susceptible to the cancer drug sorafenib. This breakthrough offers hope for more targeted cancer treatments.

SourceKarolinska Institutet·JournalNature Metabolism·DateJun 27, 2022

New study from Indiana University shows patients with chronic kidney disease who have heart attacks should be offered invasive therapy, countering dominant practices

Researchers found that invasive therapy for non-ST segment elevation myocardial infarction in patients with CKD is associated with lower mortality and reduced risk of cardiac events. The study challenges the dominant practice of offering medical management instead of invasive therapy for this population.

SourceIndiana University School of Medicine·JournalJournal of the American Heart Association·DateJun 21, 2022

NUS Medicine researchers discover glaucoma and chronic kidney disease have more in common than what meets the eye

Chronic kidney disease and glaucoma have been found to share common risk factors such as diabetes and hypertension, leading to a higher risk of developing both conditions. The study also reveals that patients with glaucoma are more likely to develop chronic kidney disease over time.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalEClinicalMedicine·TypeMeta-analysis·DateJun 21, 2022

Chinese Medical Journal review explores the role of macrophages in the progression of acute kidney injury to chronic kidney disease

A recent review article highlights the crucial role of macrophages in the progression from acute kidney injury (AKI) to chronic kidney disease (CKD). The study suggests that targeting specific signaling pathways and altering macrophage activation can prevent renal fibrosis and CKD. Therapeutic strategies such as clodronate liposomes an...

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateJun 20, 2022

Genetic screening algorithm could identify people with kidney disease risk

A new algorithm can analyze thousands of genomic variants to estimate a person's risk of developing chronic kidney disease, with the highest scores indicating tripled risk compared to the general population. Early detection may prevent many cases of kidney failure and reduce the need for transplant or dialysis.

SourceColumbia University Irving Medical Center·JournalNature Medicine·TypeData/statistical analysis·DateJun 16, 2022